These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 26289315)

  • 1. The dynamic control of signal transduction networks in cancer cells.
    Kolch W; Halasz M; Granovskaya M; Kholodenko BN
    Nat Rev Cancer; 2015 Sep; 15(9):515-27. PubMed ID: 26289315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
    Cohen PA; Donini CF; Nguyen NT; Lincet H; Vendrell JA
    Oncotarget; 2015 Dec; 6(39):41566-81. PubMed ID: 26431164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha2beta1 integrin in cancer development and chemoresistance.
    Naci D; Vuori K; Aoudjit F
    Semin Cancer Biol; 2015 Dec; 35():145-53. PubMed ID: 26297892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer targeted therapy and resistance signals].
    Yano S
    Seikagaku; 2013 Jun; 85(6):475-83. PubMed ID: 23875476
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
    Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
    Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging molecular machinery and therapeutic targets of metastasis.
    Sun Y; Ma L
    Trends Pharmacol Sci; 2015 Jun; 36(6):349-59. PubMed ID: 25939811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis.
    McCubrey JA; Abrams SL; Fitzgerald TL; Cocco L; Martelli AM; Montalto G; Cervello M; Scalisi A; Candido S; Libra M; Steelman LS
    Adv Biol Regul; 2015 Jan; 57():75-101. PubMed ID: 25453219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling by exosomal microRNAs in cancer.
    Falcone G; Felsani A; D'Agnano I
    J Exp Clin Cancer Res; 2015 Apr; 34(1):32. PubMed ID: 25886763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.
    Sherbet GV
    Cancer Lett; 2009 Jul; 280(1):15-30. PubMed ID: 19059703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches for measuring signalling plasticity in the context of resistance to targeted cancer therapies.
    Wilkes EH; Casado P; Cutillas PR
    Biochem Soc Trans; 2014 Aug; 42(4):791-7. PubMed ID: 25109959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feedback regulation in cell signalling: Lessons for cancer therapeutics.
    Nguyen LK; Kholodenko BN
    Semin Cell Dev Biol; 2016 Feb; 50():85-94. PubMed ID: 26481970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS).
    Mellier G; Pervaiz S
    Free Radic Res; 2012 Aug; 46(8):996-1003. PubMed ID: 22559302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells: an approach to identify newer therapeutic targets.
    Srivastava S; Krishna S
    J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminolysis and autophagy in cancer.
    Villar VH; Merhi F; Djavaheri-Mergny M; Durán RV
    Autophagy; 2015; 11(8):1198-208. PubMed ID: 26054373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.
    Kubisch J; Türei D; Földvári-Nagy L; Dunai ZA; Zsákai L; Varga M; Vellai T; Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):252-61. PubMed ID: 23810837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.